El-Sherbiny, Yasser M.
El-Jawhari, Jehan J.
Moseley, Timothy A.
McGonagle, Dennis
Jones, Elena
Funding for this research was provided by:
AO Foundation (S-16-132E)
the AO foundation
Article History
Received: 28 November 2017
Accepted: 17 August 2018
First Online: 10 September 2018
Competing Interests
: T.A.M. has been previously employed by NuVasive, Inc. but received no direct financial compensation that would have influenced its outcome. E.J. and D.M. received materials and consumables funding from NuVasive, Inc. T.A.M., E.J., D.M. and Y.M.E. have filed a utility patent, WO/2017/100339A1, “Immunomodulation with implantation of cellular allograft bone into a non-bony site” based upon intellectual property identified in this manuscript. J.J.E. has no competing interests.